logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5632.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Perspectives on advancing countermeasures for Filovirus disease: Report from a multi-sector meeting

Sprecher A, Cross RW, Marzi A, Martins KA, Wolfe D,  et al.
2023-08-19 • Journal of Infectious Diseases
2023-08-19 • Journal of Infectious Diseases
Although there are now approved treatments and vaccines for Ebola virus disease (EVD), the case fatality of EVD remains unacceptably high even when treated with the newly approved therap...
Journal Article
|
Commentary

Revisiting the minimum incubation period of Zaire ebolavirus

Kofman AD, Haberling DL, Mbuyi G, Martel LD, Whitesell AN,  et al.
2023-08-18 • Lancet Infectious Diseases
2023-08-18 • Lancet Infectious Diseases
Journal Article
|
Research

Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment

Cross RW, Bornholdt ZA, Prasad AN, Geisbert JB, Borisevich V,  et al.
2020-07-27 • Nature Communications
2020-07-27 • Nature Communications
A replication-competent vesicular stomatitis virus vaccine expressing the Ebola virus (EBOV) glycoprotein (GP) (rVSV-ZEBOV) was successfully used during the 2013-16 EBOV epidemic. Additi...
Journal Article
|
Review

Ebola

Feldmann H, Sprecher A, Geisbert TW
2020-05-07 • New England Journal of Medicine
2020-05-07 • New England Journal of Medicine